Products for Research Use Only

MJ33 (lithium salt)

CAT: 0804-HY-115062-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-115062-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
MJ33 is an active-site-directed, specific, competitive, and reversible phospholipase A2 (PLA2) inhibitor. MJ33 blocks the calcium-independent phospholipase A2 (iPLA2) activity of Prdx6[1].
CAS Number
1007476-63-2
UNSPSC
12352211
Target
Phospholipase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/mj33-lithium-salt.html
Purity
99.0
Solubility
DMSO : ≥ 0.25mg/mL|Ethanol : 2 mg/mL (ultrasonic; warming)
Smiles
O=P(OC)(OC(COCC(F)(F)F)COCCCCCCCCCCCCCCCC)O[Li]
Molecular Formula
C22H43F3LiO6P
Molecular Weight
498.48
References & Citations
[1]Fisher AB, Dodia C, Chander A, Jain M. A competitive inhibitor of phospholipase A2 decreases surfactant phosphatidylcholine degradation by the rat lung. Biochem J. 1992 Dec 1;288 (Pt 2) (Pt 2) :407-11.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported